메뉴 건너뛰기




Volumn 49, Issue 2, 2007, Pages 73-78

Antiretroviral treatment for HIV infection/aids and the risk of developing hyperglycemia and hyperlipidemia

Author keywords

AIDS; Antiretroviral therapy; Dyslipidemia; HAART; Hyperglycemia

Indexed keywords

ANTIRETROVIRUS AGENT; CHOLESTEROL; CREATININE; GLUCOSE; PROTEINASE INHIBITOR; TRIACYLGLYCEROL;

EID: 34248392637     PISSN: 00364665     EISSN: 16789946     Source Type: Journal    
DOI: 10.1590/s0036-46652007000200002     Document Type: Article
Times cited : (19)

References (23)
  • 1
    • 34248324635 scopus 로고    scopus 로고
    • BANDEIRA, F.; MACEDO, G.; CALDAS, G.; GRIZ, L. & FARIA, M. - Diabetes mellitus tipo 2. In. _ Endocrinologia. Diagnóstico e tratamento. Rio de Janeiro, MEDSI, 1998. p. 151-161.
    • BANDEIRA, F.; MACEDO, G.; CALDAS, G.; GRIZ, L. & FARIA, M. - Diabetes mellitus tipo 2. In. _ Endocrinologia. Diagnóstico e tratamento. Rio de Janeiro, MEDSI, 1998. p. 151-161.
  • 2
    • 0033220714 scopus 로고    scopus 로고
    • BARTLETT, J.G. - Toxicity of antiretroviral agents. Hopkins HIV Rep., 11: 2-12,1999.
    • BARTLETT, J.G. - Toxicity of antiretroviral agents. Hopkins HIV Rep., 11: 2-12,1999.
  • 3
    • 0032578921 scopus 로고    scopus 로고
    • Images in clinical medicine. Lipodystrophy associated with an HIV-protease inhibitor
    • CARR, A. & COOPER, D.A. - Images in clinical medicine. Lipodystrophy associated with an HIV-protease inhibitor. New Engl. J. Med., 339: 1296, 1998.
    • (1998) New Engl. J. Med , vol.339 , pp. 1296
    • CARR, A.1    COOPER, D.A.2
  • 4
    • 0032551258 scopus 로고    scopus 로고
    • Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance
    • CARR, A.; SAMARAS, K.; CHISHOLM, D.J. & COOPER, D.A. - Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance. Lancet, 351: 1881-1883, 1998.
    • (1998) Lancet , vol.351 , pp. 1881-1883
    • CARR, A.1    SAMARAS, K.2    CHISHOLM, D.J.3    COOPER, D.A.4
  • 5
    • 0033583977 scopus 로고    scopus 로고
    • Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hiperlipidaemia, and diabetes mellitus: A cohort study
    • CARR, A.; SAMARAS, K.; THORISDOTTIR, A. et al. - Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hiperlipidaemia, and diabetes mellitus: a cohort study. Lancet, 353: 2093-2099, 1999.
    • (1999) Lancet , vol.353 , pp. 2093-2099
    • CARR, A.1    SAMARAS, K.2    THORISDOTTIR, A.3
  • 6
    • 0031730054 scopus 로고    scopus 로고
    • Hyperlipidaemia following treatment with protease inhibitors in patients with HIV-1 infection
    • CHURCHILL, D.R.; PYM, A.S.; BABIKER, A.G.; BACK, D.J. & WEBER, J. N. - Hyperlipidaemia following treatment with protease inhibitors in patients with HIV-1 infection. J. Clin. Pharmacol., 46: 518-519, 1998.
    • (1998) J. Clin. Pharmacol , vol.46 , pp. 518-519
    • CHURCHILL, D.R.1    PYM, A.S.2    BABIKER, A.G.3    BACK, D.J.4    WEBER, J.N.5
  • 7
    • 0033153014 scopus 로고    scopus 로고
    • Changes in body habitus and serum lipid abnormalities in HIV-positive women on highly active antiretroviral therapy (HAART)
    • DONG, K.L.; BAUSSERMAN, L.L.; FLYNN, M.M. et al. - Changes in body habitus and serum lipid abnormalities in HIV-positive women on highly active antiretroviral therapy (HAART). J. Acquir. Immune Defic. Syndr., 21: 107-113, 1999.
    • (1999) J. Acquir. Immune Defic. Syndr , vol.21 , pp. 107-113
    • DONG, K.L.1    BAUSSERMAN, L.L.2    FLYNN, M.M.3
  • 8
  • 9
    • 0033545441 scopus 로고    scopus 로고
    • Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy
    • GERVASONI, C.; RIDOLFO, A.L.; TRIFIRÒ, G. et al. - Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy. AIDS, 13: 465-471, 1999.
    • (1999) AIDS , vol.13 , pp. 465-471
    • GERVASONI, C.1    RIDOLFO, A.L.2    TRIFIRÒ, G.3
  • 10
    • 0031556850 scopus 로고    scopus 로고
    • Benign symmetric lipomatosis associated with protease inhibitors
    • HENGEL, R.L.; WATTS, N.B. & LENNOX, J.L. - Benign symmetric lipomatosis associated with protease inhibitors. Lancet, 350: 1596, 1997.
    • (1997) Lancet , vol.350 , pp. 1596
    • HENGEL, R.L.1    WATTS, N.B.2    LENNOX, J.L.3
  • 11
    • 0030763107 scopus 로고    scopus 로고
    • Hypertrophy of the breasts in a patient treated with indinavir
    • HERRY, I.; BERNARD, L.; TRUCHIS, P. & PERRONNE, C. - Hypertrophy of the breasts in a patient treated with indinavir. Clin. infect. Dis., 25: 937-938, 1997.
    • (1997) Clin. infect. Dis , vol.25 , pp. 937-938
    • HERRY, I.1    BERNARD, L.2    TRUCHIS, P.3    PERRONNE, C.4
  • 13
    • 34248373568 scopus 로고    scopus 로고
    • Lipodistrofia e dislipidemia na infecção pelo HIV/AIDS. Uma breve revisão
    • MAGRO, D.O.; MORAES, M.J.; MOREIRA-FILHO, D.C. & PEDRO, R.J. - Lipodistrofia e dislipidemia na infecção pelo HIV/AIDS. Uma breve revisão. J. bras. AIDS, 1: 14-18, 2000.
    • (2000) J. bras. AIDS , vol.1 , pp. 14-18
    • MAGRO, D.O.1    MORAES, M.J.2    MOREIRA-FILHO, D.C.3    PEDRO, R.J.4
  • 14
    • 0033924871 scopus 로고    scopus 로고
    • Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection
    • MALLAL, S.A.; JOHN, M.; MOORE, C.B.; JAMES, I.R. & McKINNON, E.J. - Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection. AIDS, 14: 1309-1316, 2000.
    • (2000) AIDS , vol.14 , pp. 1309-1316
    • MALLAL, S.A.1    JOHN, M.2    MOORE, C.B.3    JAMES, I.R.4    McKINNON, E.J.5
  • 15
    • 0033582187 scopus 로고    scopus 로고
    • Impaired glucose tolerance in HIV-positive patients receiving and those not receiving protease inhibitors
    • MAUSS, S.; WOLF, E. & JAEGER, H. - Impaired glucose tolerance in HIV-positive patients receiving and those not receiving protease inhibitors. Ann. intern. Med., 130: 162-163, 1999.
    • (1999) Ann. intern. Med , vol.130 , pp. 162-163
    • MAUSS, S.1    WOLF, E.2    JAEGER, H.3
  • 16
    • 0345151837 scopus 로고    scopus 로고
    • Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV cohort study
    • PERIARD, D.; TELENTI, A.; SUDRE, P. et al. - Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV cohort study. Circulation, 100: 700-705, 1999.
    • (1999) Circulation , vol.100 , pp. 700-705
    • PERIARD, D.1    TELENTI, A.2    SUDRE, P.3
  • 17
    • 0032776658 scopus 로고    scopus 로고
    • Alterations in serum levels of lipid and lipoproteins with indinavir therapy for human immunodeficiency virus-infected patients
    • ROBERTS, A.D.; MUESING, R.A.; PARENTI, D.M. et al. - Alterations in serum levels of lipid and lipoproteins with indinavir therapy for human immunodeficiency virus-infected patients. Clin. infect. Dis., 29: 441-443, 1999.
    • (1999) Clin. infect. Dis , vol.29 , pp. 441-443
    • ROBERTS, A.D.1    MUESING, R.A.2    PARENTI, D.M.3
  • 18
    • 0033396957 scopus 로고    scopus 로고
    • Fat distribution and metabolic changes in patients with HIV infection
    • SAFRIN, S. & GRUNFELD, C. - Fat distribution and metabolic changes in patients with HIV infection. AIDS, 13: 2493-2505, 1999.
    • (1999) AIDS , vol.13 , pp. 2493-2505
    • SAFRIN, S.1    GRUNFELD, C.2
  • 19
    • 0033391005 scopus 로고    scopus 로고
    • A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy
    • SAINT-MARC, T.; PARTISANI, M.; POIZOT-MARTIN, I. et al. - A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy. AIDS, 13: 1659-1667, 1999.
    • (1999) AIDS , vol.13 , pp. 1659-1667
    • SAINT-MARC, T.1    PARTISANI, M.2    POIZOT-MARTIN, I.3
  • 20
    • 0033040212 scopus 로고    scopus 로고
    • Hyperlipidemia under treatment with proteinase inhibitors
    • SEGERER, S.; BOGNER, J.R.; WALLI, R.; LOCH, O. & GOEBEL, F.-D. - Hyperlipidemia under treatment with proteinase inhibitors. Infection, 27: 77-81, 1999.
    • (1999) Infection , vol.27 , pp. 77-81
    • SEGERER, S.1    BOGNER, J.R.2    WALLI, R.3    LOCH, O.4    GOEBEL, F.-D.5
  • 21
    • 0030926042 scopus 로고    scopus 로고
    • Marked hyperlipidaemia on ritonavir therapy
    • SULLIVAN, A.K. & NELSON, M.R. - Marked hyperlipidaemia on ritonavir therapy. AIDS, 11: 938-939, 1997.
    • (1997) AIDS , vol.11 , pp. 938-939
    • SULLIVAN, A.K.1    NELSON, M.R.2
  • 22
    • 0034631873 scopus 로고    scopus 로고
    • Effects of protease inhibitors on hyperglycemia, hyperlipidemia, and lipodystrophy: A 5-year cohort study
    • TSIODRAS, S.; MANTZOROS, C.; HAMMER, S. & SAMORE, M. - Effects of protease inhibitors on hyperglycemia, hyperlipidemia, and lipodystrophy: a 5-year cohort study. Arch. intern. Med., 160: 2050-2056, 2000.
    • (2000) Arch. intern. Med , vol.160 , pp. 2050-2056
    • TSIODRAS, S.1    MANTZOROS, C.2    HAMMER, S.3    SAMORE, M.4
  • 23
    • 0032537042 scopus 로고    scopus 로고
    • Indinavir-associated lipodystrophy
    • VIRABEN, R. & AQUILINA, C. - Indinavir-associated lipodystrophy. AIDS, 12: 37-39, 1998.
    • (1998) AIDS , vol.12 , pp. 37-39
    • VIRABEN, R.1    AQUILINA, C.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.